Literature DB >> 30263468

Sigumjang (fermented barley bran) water-soluble extracts inhibit the expression of adipogenic and lipogenic regulators in 3T3-L1 adipocytes.

Hojeong Jeong1, Sangdon Lee1, Sang Wook Kim1, Dongyeop Kim1,2, Gi Dong Han1.   

Abstract

Sigumjang prepared from fermented barley bran is a traditional fermented food found only in the Gyeongsang-do area of South Korea. There have been no studies reported to date despite the potential bioactivities of sigumjang. In this study, the anti-obesity activities of sigumjang extracts (SEs) during 3T3-L1 differentiation into adipocytes were investigated. SEs inhibited adipocyte differentiation by suppressing the CCAAT/enhancer binding protein-β and sterol regulatory element binding protein-1c expression in the early stage of differentiation, followed by the suppression of the peroxisome proliferator-activated receptor-γ, CCAAT/enhancer binding protein-α, and adiponectin. These changes in adipogenic markers induced inhibition of lipogenesis via down-regulation of mainly fatty acid synthase, acetyl-CoA carboxylase, fatty acid binding protein 4, and perilipin. These results were more significant in the extract of sigumjang fermented with isolated Bacillus amyloliquefaciens MFST compared to naturally fermented sigumjang group. SEs can be considered as a useful material for developing food with health benefits and anti-obesity properties.

Entities:  

Keywords:  3T3-L1 cells; adipogenesis; fermented barley bran foods; lipogenesis

Year:  2016        PMID: 30263468      PMCID: PMC6049242          DOI: 10.1007/s10068-016-0264-7

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  32 in total

1.  Differentiation kinetics of in vitro 3T3-L1 preadipocyte cultures.

Authors:  Hong Song; Kim C O'Connor; Kyriakos D Papadopoulos; David A Jansen
Journal:  Tissue Eng       Date:  2002-12

Review 2.  Adipose tissue: new therapeutic targets from molecular and genetic studies--IASO Stock Conference 2003 report.

Authors:  S R Farmer; J Auwerx
Journal:  Obes Rev       Date:  2004-11       Impact factor: 9.213

Review 3.  The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences.

Authors:  Sarah de Ferranti; Dariush Mozaffarian
Journal:  Clin Chem       Date:  2008-04-24       Impact factor: 8.327

4.  Inhibitory effects of tannic acid in the early stage of 3T3-L1 preadipocytes differentiation by down-regulating PPARγ expression.

Authors:  Fangyuan Nie; Yan Liang; Hang Xun; Jia Sun; Fei He; Xiaofeng Ma
Journal:  Food Funct       Date:  2015-03       Impact factor: 5.396

Review 5.  Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes.

Authors:  B M Spiegelman; L Choy; G S Hotamisligil; R A Graves; P Tontonoz
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

Review 6.  The transcriptional basis of adipocyte development.

Authors:  Evan D Rosen
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2005-07       Impact factor: 4.006

7.  Alteration by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells.

Authors:  P C Liu; M A Phillips; F Matsumura
Journal:  Mol Pharmacol       Date:  1996-06       Impact factor: 4.436

8.  Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha.

Authors:  J M Stephens; P H Pekala
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

9.  Decreased activity and enhanced nuclear export of CCAAT-enhancer-binding protein beta during inhibition of adipogenesis by ceramide.

Authors:  Kam M Sprott; Michael J Chumley; Janean M Hanson; Rick T Dobrowsky
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

10.  Fisetin induces Sirt1 expression while inhibiting early adipogenesis in 3T3-L1 cells.

Authors:  Sang Chon Kim; Yoo Hoon Kim; Sung Wook Son; Eun-Yi Moon; Suhkneung Pyo; Sung Hee Um
Journal:  Biochem Biophys Res Commun       Date:  2015-10-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.